Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Uveal Melanoma 4Macular Edema 2von Hippel-Lindau Disease 1Retinal Diseases 1Neurofibromatosis 1 1Neurofibroma 1Neoplasms 1Melanoma 1Glaucoma, Neovascular 1Conjunctival Neoplasms 1

Interventions

Ranibizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Conjunctival Neoplasms × Ranibizumab × Clear all
NCT00456495 2017-07-21

Effect of Ranibizumab on Malignant Conjunctival Neoplasia

The New York Eye Cancer Center

Phase 1 Completed
5 enrolled 6 charts

Conjunctival Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡